Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Army
Federal Trade Commission
AstraZeneca
Daiichi Sankyo
Medtronic

Generated: July 22, 2019

DrugPatentWatch Database Preview

LOPURIN Drug Profile

Try a free trialSee Plans and Pricing

« Back to Dashboard

Which patents cover Lopurin, and what generic alternatives are available?

Lopurin is a drug marketed by Abbott and Dr Reddys La and is included in three NDAs.

The generic ingredient in LOPURIN is allopurinol. There are twenty-two drug master file entries for this compound. Forty-nine suppliers are listed for this compound. Additional details are available on the allopurinol profile page.

Summary for LOPURIN
Drug patent expirations by year for LOPURIN
Pharmacology for LOPURIN
Medical Subject Heading (MeSH) Categories for LOPURIN

US Patents and Regulatory Information for LOPURIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott LOPURIN allopurinol TABLET;ORAL 018297-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys La LOPURIN allopurinol TABLET;ORAL 071587-001 Apr 2, 1987 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Abbott LOPURIN allopurinol TABLET;ORAL 018297-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Dr Reddys La LOPURIN allopurinol TABLET;ORAL 071586-001 Apr 2, 1987 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

Subscribe to access the full database, or try a Free Trial

Expired US Patents for LOPURIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Abbott LOPURIN allopurinol TABLET;ORAL 018297-001 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Abbott LOPURIN allopurinol TABLET;ORAL 018297-002 Approved Prior to Jan 1, 1982 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
QuintilesIMS
Accenture
Fuji
McKinsey
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.